Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency -Sptlc2 conditional

Etsuko Ohta1, Takashi Ohira, Kenta Matsue

  • 1Safety Assessment, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.

Experimental Animals
|November 10, 2009
PubMed

Insights

Serine palmitoyltransferase (SPT) deficiency causes rapid intestinal cell death and tissue atrophy. This highlights SPT

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Sphingolipids are essential cellular components.
  • Serine palmitoyltransferase (SPT) is key to sphingolipid synthesis.
  • Complete SPT gene knockout is lethal, limiting in vivo study.

Purpose of the Study:

  • Investigate the in vivo function of SPT.
  • Determine the effects of Sptlc2 deficiency in a conditional knockout mouse model.

Main Methods:

  • Developed a conditional knockout (cKO) mouse lacking Sptlc2.
  • Induction of knockout and observation of phenotypic changes over 72 hours.
  • Histological analysis of gastrointestinal, lymphoid, and hematopoietic tissues.

Main Results:

  • Rapid single-cell necrosis observed in intestinal crypt epithelia within 24 hours.
  • Significant decreases in spleen and thymus weights, reticulocytes, and lymphocytes by 48-72 hours.
  • Histological evidence of gastrointestinal mucosal atrophy and lymphoid/hematopoietic tissue depletion.

Conclusions:

  • SPT is crucial for maintaining gastrointestinal mucosa integrity.
  • Sptlc2 deficiency leads to rapid intestinal cell necrosis and subsequent tissue atrophy.
  • SPT plays a vital role in lymphoid and hematopoietic tissue maintenance.

Related Concept Videos